TP53 and breast cancer: However, since the patient met Chompret's criteria (2015, Table 1) with multiple cancers and early-onset breast cancer in the ‘core' tumors, we performed germline TP53 genetic testing (FALCO Ltd., Kyoto, Japan), with her consent (written informed consent was obtained from the patient).